iStent Infinite

Device Glaukos Corporation
Total Payments
$693,762
Transactions
382
Doctors
10
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $693,762 382 10

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $677,212 359 97.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,650 17 1.8%
Consulting Fee $3,900 6 0.6%

Payments by Type

Research
$677,212
359 transactions
General
$16,550
23 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WITH MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA Glaukos Corporation $530,709 0
A Prospective, Randomized, Controlled, Comparative Multicenter Clinical Study of Glaukos Trabecular Micro-Bypass System Model iS3 Infinite vs. Hydrus in Adult Subjects With Primary Open-Angle Glaucoma (POAG) Glaukos Corporation $146,503 0

Top Doctors Receiving Payments for iStent Infinite

Doctor Specialty Location Total Records
Unknown Cleveland, OH $686,862 369
, M.D Ophthalmology New York, NY $2,600 4
, O.D Optometrist Wabash, IN $915.00 1
, O.D Optometrist Wabash, IN $915.00 1
, M.D Cornea and External Diseases Specialist Plymouth Meeting, PA $650.00 1
, M.D Ophthalmology Sioux Falls, SD $650.00 1
, O.D Optometrist Fort Wayne, IN $600.00 1
, O. D Optometrist Fort Wayne, IN $360.00 1
, O.D Optometrist Marion, IN $150.00 1
, O.D Optometrist Chesterton, IN $30.00 1
, O.D Optometrist North Manchester, IN $30.00 1

About iStent Infinite

iStent Infinite is a device associated with $693,762 in payments to 10 healthcare providers, recorded across 382 transactions in the CMS Open Payments database. The primary manufacturer is Glaukos Corporation.

Payment data is available from 2024 to 2024. In 2024, $693,762 was paid across 382 transactions to 10 doctors.

The most common payment nature for iStent Infinite is "Unspecified" ($677,212, 97.6% of total).

iStent Infinite is associated with 2 research studies, including "A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WITH MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA" ($530,709).